Deltagen Inc
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorpo… Read more
Deltagen Inc (DGEN) - Total Assets
Latest total assets as of December 2014: $1.84 Million USD
Based on the latest financial reports, Deltagen Inc (DGEN) holds total assets worth $1.84 Million USD as of December 2014.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Deltagen Inc - Total Assets Trend (1999–2015)
This chart illustrates how Deltagen Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Deltagen Inc - Asset Composition Analysis
Current Asset Composition (December 2015)
Deltagen Inc's total assets of $1.84 Million consist of 10.4% current assets and 89.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.6% |
| Accounts Receivable | $123.00K | 6.8% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $26.00K | 1.5% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1999–2015)
This chart illustrates how Deltagen Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Deltagen Inc's current assets represent 10.4% of total assets in 2015, a decrease from 24.2% in 1999.
- Cash Position: Cash and equivalents constituted 2.6% of total assets in 2015, down from 12.5% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1999.
- Asset Diversification: The largest asset category is accounts receivable at 6.8% of total assets.
Deltagen Inc Competitors by Total Assets
Key competitors of Deltagen Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
OJsys Inc
PINK:OJSY
|
USA | $8.03 Million |
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
Deltagen Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Deltagen Inc generates 0.43x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Deltagen Inc is currently not profitable relative to its asset base.
Deltagen Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.30 | 11.39 | 9.13 |
| Quick Ratio | 2.30 | 11.39 | 9.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $129.00K | $ 5.09 Million | $ 107.71 Million |
Deltagen Inc - Advanced Valuation Insights
This section examines the relationship between Deltagen Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -2.2% |
| Total Assets | $1.80 Million |
| Market Capitalization | $0.94 USD |
Valuation Analysis
Below Book Valuation: The market values Deltagen Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Deltagen Inc's assets decreased by 2.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Deltagen Inc (1999–2015)
The table below shows the annual total assets of Deltagen Inc from 1999 to 2015.
| Year | Total Assets | Change |
|---|---|---|
| 2015-12-31 | $1.80 Million | -2.23% |
| 2014-12-31 | $1.84 Million | -9.98% |
| 2013-12-31 | $2.04 Million | -68.32% |
| 2012-12-31 | $6.45 Million | -9.79% |
| 2010-12-31 | $7.15 Million | -7.83% |
| 2009-12-31 | $7.76 Million | +7.93% |
| 2008-12-31 | $7.19 Million | -4.44% |
| 2007-12-31 | $7.53 Million | -22.16% |
| 2006-12-31 | $9.67 Million | -38.56% |
| 2005-12-31 | $15.73 Million | -80.96% |
| 2002-12-31 | $82.64 Million | -24.22% |
| 2001-12-31 | $109.05 Million | -16.15% |
| 2000-12-31 | $130.06 Million | +1819.97% |
| 1999-12-31 | $6.77 Million | -- |